trending Market Intelligence /marketintelligence/en/news-insights/trending/HaZiTdL6qK8cEz8KFv1MlQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Report: 5 PE firms submit 1st-round bids for CapVest's Curium Pharma

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

Report: 5 PE firms submit 1st-round bids for CapVest's Curium Pharma

CapVest Partners LLP received initial bids for Paris-based Curium SAS from private equity firms CVC Capital Partners Ltd., Bain Capital LP, Clayton Dubilier & Rice LLC, Nordic Capital and PAI Partners, Bloomberg News reported, citing people familiar with the matter.

CapVest initiated a bidding process for the sale of Curium in November 2019. The nuclear medicine materials business is expected to sell for at least $3 billion, according to the people, who added that the next round of bids are expected in February.

Representatives for CapVest, CVC, Bain, Nordic Capital and PAI declined to comment, while Clayton Dubilier & Rice did not immediately respond to Bloomberg's request for comment.

Curium manufactures medical imaging supplies and provides materials used in nuclear medicine to help diagnose cancer as well as heart, brain and bone diseases.